Featured Research

from universities, journals, and other organizations

How mast cells set immune defense on the right track

Date:
June 7, 2010
Source:
Helmholtz Association of German Research Centres
Summary:
Researchers in Germany have now been able to show that previously underrated immune cells, so-called mast cells, decide at a very early stage of an infection which way the defense has to go. They only produce the crucial messenger substance beta-interferon during a viral infection, not during a bacterial infection.

Mast cells with Salmonella bacteria.
Credit: Manfred Rohde, HZI

In the event of an infection, the immune system releases messenger substances. These molecules can either activate immune cells to defeat invading pathogens, or inhibit them to prevent an excessive immune reaction. For this, the immune system has to decide very quickly what mixture of activating and inhibiting messenger molecules leads to a successful defence.

Related Articles


Researchers from the Helmholtz-Centre for Infection Research in Braunschweig, Germany, have now been able to show that hitherto underrated immune cells, so-called mast cells, decide at a very early stage of an infection which way the defence has to go. They only produce the crucial messenger substance beta-interferon during a viral infection, not during a bacterial infection. The reason for this: While on the one hand the molecule always helps to defeat viruses, it hinders on the other hand important immune cells to kill bacteria -- and thus impairs the defence. The group's results have now been published in the Proceedings of the National Academy of Sciences.

Mast cells play a central role during allergic reactions, a function researchers have concentrated on until now. They reside directly under the skin and mucosae, and react immediately when an allergenic substance enters the body. As a result, reddened mucosae, swelling, runny eyes and a runny nose occur. However, mast cells also seem to have a crucial, but only superficially understood, function during pathogenic defence. "They wait precisesly at that position where pathogens enter the body," says Nelson O. Gekara, researcher in the group "Molecular Immunology" at the HZI, "and thus belong to the very first line of immune defence."

To investigate how mast cells react when they come in contact with bacteria and viruses, the HZI-researchers incubated mast cells and pathogens together in a petri dish. Then, they measured what messenger substances the cells produced. As soon as a virus infection occurred, the scientists were then able to detect beta-interferon, produced by the mast cells. Conversely, during a bacterial infection, no beta-interferon was found. "Until now it has been unknown that mast cells can virtually decide whether they produce beta-interferon or not," says Nicole Dietrich who did research on the mast cells. "During a viral infection, beta-interferon helps because it activates mechanisms in surrounding cells that support the virus defence."

The researchers found the reason for why mast cells do not produce beta-interferon during bacterial infections in the defence line that follows mast cells: "Beta-interferon inhibits precisely those cells that quickly eliminate invading bacteria," says Nicole Dietrich. Thus, mast cells determine very early which direction the immune defence is taking.

Important for this decision making are receptors on the surface of all immune cells: So-called "Toll-like receptors" activate mast cells as soon as a pathogen enters the body. When the receptors are triggered, mast cells produce a number of messenger substances that attract cells or keep them at distance, activate or inhibit them and thus regulate an optimised immune response.

"To produce beta-interferon, immune cells have to absorb the receptors and transport them into the cell interior. During a bacterial infection, mast cells refuse to incorporate the receptor and thus do not produce beta-interferon," says Nelson O. Gekara. This is another step towards understanding the complex network of messenger substances, immune cell and pathogen defence. "It seems as if every line of defence can precisely decide which step will be the next and best."


Story Source:

The above story is based on materials provided by Helmholtz Association of German Research Centres. Note: Materials may be edited for content and length.


Journal Reference:

  1. N. Dietrich, M. Rohde, R. Geffers, A. Kroger, H. Hauser, S. Weiss, N. O. Gekara. Mast cells elicit proinflammatory but not type I interferon responses upon activation of TLRs by bacteria. Proceedings of the National Academy of Sciences, 2010; 107 (19): 8748 DOI: 10.1073/pnas.0912551107

Cite This Page:

Helmholtz Association of German Research Centres. "How mast cells set immune defense on the right track." ScienceDaily. ScienceDaily, 7 June 2010. <www.sciencedaily.com/releases/2010/06/100607111308.htm>.
Helmholtz Association of German Research Centres. (2010, June 7). How mast cells set immune defense on the right track. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/2010/06/100607111308.htm
Helmholtz Association of German Research Centres. "How mast cells set immune defense on the right track." ScienceDaily. www.sciencedaily.com/releases/2010/06/100607111308.htm (accessed October 31, 2014).

Share This



More Health & Medicine News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

U.S. Ebola Response Measures Demonstrated

U.S. Ebola Response Measures Demonstrated

AP (Oct. 31, 2014) Officials in the Washington area showed off Ebola response measures being taken at Dulles International Airport and the National Institutes of Health. (Oct. 31) Video provided by AP
Powered by NewsLook.com
Fauci Says Ebola Risk in US "essentially Zero"

Fauci Says Ebola Risk in US "essentially Zero"

AP (Oct. 30, 2014) NIAID Director Anthony Fauci said the risk of Ebola becoming an epidemic in the U.S. is essentially zero Thursday at the Washington Ideas Forum. He also said an Ebola vaccine will be tested in West Africa in the next few months. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Nurse Defies Ebola Quarantine With Bike Ride

Nurse Defies Ebola Quarantine With Bike Ride

AP (Oct. 30, 2014) A nurse who vowed to defy Maine's voluntary quarantine for health care workers who treated Ebola patients followed through on her promise Thursday, leaving her home for an hour-long bike ride. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Pot-Infused Edibles Raise Concerns in Colorado

Pot-Infused Edibles Raise Concerns in Colorado

AFP (Oct. 30, 2014) Colorado may have legalized marijuana for recreational use, but the debate around the decision still continues, with a recent - failed - attempt to ban cannabis-infused edibles. Duration: 01:53 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins